INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-2152418334-antibody-drug-conjugate-render]( "Thunderstruck By Antibody-Drug Conjugates")
Thunderstruck By Antibody-Drug ConjugatesAntibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.
-
![Biophysical Tools For Biotherapeutic Development]( "Biophysical Tools For Biotherapeutic Development")
Biophysical Tools For Biotherapeutic DevelopmentDiscover essential analytical techniques in biotherapeutics development, as well as explore ITC, DSC, and Rheology—powerful tools for understanding formulation, stability, and efficacy in drug development.
-
![CRISPR Meets LNPs: A New Era In Cell And Gene Therapies]( "CRISPR Meets LNPs: A New Era In Cell And Gene Therapies")
CRISPR Meets LNPs: A New Era In Cell And Gene TherapiesExplore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.
-
![quality control, sterile pharmaceutical manufacturing facility-GettyImages-2277115553]( "Integrated QC As A Development Strategy: Reducing Late-Stage Analytical Risk")
Integrated QC As A Development Strategy: Reducing Late-Stage Analytical RiskLearn how early QC integration, proactive analytical risk management, and cross-functional collaboration can improve validation readiness, reduce development surprises, strengthen release testing predictability, and help protect critical clinical manufacturing timelines.
-
Biopharma Production And Quality Control With Electrophoresis2/20/2025
Discover how Kaneka Eurogentec, a leading provider of custom DNA synthesis and molecular biology services, enhanced their fragment analysis to achieve higher efficiency and accuracy in their workflows.
-
Organ-On-A-Chip Technology Unlocks Patient-Derived Precision Medicine6/25/2026
Personalized medicine struggles with models that fail to reflect real human biology. Organ-on-a-Chip systems recreate tissue complexity, helping predict patient-specific treatment responses.
-
Safety Of Injectables: Ensuring Purity Via Endotoxin Testing7/28/2026
Advance pharmaceutical quality and sustainability by adopting recombinant factor C testing for reliable, animal-free endotoxin detection.
-
Accelerating Clinical Development: Modern Tools In Process Chemistry1/23/2025
Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.
-
Techniques For PEGylation Site Identification7/3/2025
Examine how our innovative methods enable the precise identification of PEGylation sites, unlocking deeper insights into the structure, stability, and function of biotherapeutics.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-1214921728-lab-glassware-beaker-vial-test-tube]( "Enhance The Solubility Of Your APIs With AI")
When it comes to solid dosage formulations, the most common challenge formulators face is poor solubility. In numbers: 70% of drugs in development are poorly soluble.
-
![GettyImages-899692870-lab-cleanroom-research-microscope]( "Peptide Development Strategies")
Peptides occupy a therapeutic niche between small molecules and large biologics. We understand the fundamental physiological challenges to peptide delivery and that there is no “one-size-fits-all” approach for formulation design.
-
Enhance your research and obtain exceptional imaging and analysis with a configurable and upgradeable high-content screening system that captures high-definition images and robust data from 2D and 3D assays.
-
![GettyImages-1294339649 drug development, cleanroom]( "Simplify Your Linker-Payload Synthesis")
By streamlining the synthesis pathways, see how these products can effectively diminish the requisite number of developmental and manufacturing stages essential for generating payloads.
-
![GettyImages-1218520471-development-research-lab-PPE]( "Early Development: Accelerating Molecules Through To Proof-Of-Concept")
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
